CAMBRIDGE, Mass. and DUBLIN, Oct. 30, 2019 /PRNewswire/ -- Biogen Inc. (Nasdaq: BIIB) and Alkermes plc (Nasdaq: ALKS) today announced that the U.S.…
sciencecityOctober 31, 2019
The investigational KRAS G12C inhibitor MRTX849 yielded clinical responses in patients with non-small cell lung…
sciencecityOctober 30, 2019
Oxford BioDynamics has announced that the first patient has been enrolled in the REFINE-ALS clinical…
sciencecityOctober 29, 2019
MIT chemists have devised a way to synthesize polymers that can break down more readily…
sciencecityOctober 29, 2019
Autism spectrum disorders affect one in 59 American children by age eight. With no known…
sciencecityOctober 28, 2019
Inside a living cell, many important messages are communicated via interactions between proteins. For these…
sciencecityOctober 25, 2019
The key to treating blood pressure might lie in people who are “resistant” to developing…
sciencecityOctober 25, 2019
No one expected this. In March, Biogen and its collaboration partner, Tokyo-based Eisai, announced they were discontinuing the global Phase…
sciencecityOctober 24, 2019
For centuries, women have been dismissed as emotional and, thus, unreliable. The “scientific” proof? Hormones.…
sciencecityOctober 24, 2019
